R&G PharmaStudies (301333.SZ): Harmony Growth Phase II and Harmony Health have collectively reduced their holdings by 0.29%.

R&G PharmaStudies (301333.SZ) announced that on February 26, 2025, the company received a notice from Harmony Growth II and Harmony Healthy regarding the reduction of the company's shares reaching a multiple of 1%. From December 6, 2024 to February 26, 2025, Harmony Growth II and Harmony Healthy collectively reduced their holdings of the company's shares by 278,920 shares through centralized bidding trading, accounting for 0.2917% of the company's current total share capital of 95,605,456 shares (excluding 975,800 shares held in the current repurchase special securities account).